News Focus
News Focus
Followers 50
Posts 9237
Boards Moderated 0
Alias Born 01/13/2007

Re: FooBarAndGrill post# 20581

Tuesday, 11/15/2022 8:39:39 AM

Tuesday, November 15, 2022 8:39:39 AM

Post# of 21574
40 weeks is a secondary endpoint, observational only. Final efficacy endpoint from dosing is at 28 weeks and that's what we will get in a few weeks. 3 months later they go back and see how long the proposed benefit persists in patients.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TAOX News